ArticleBMJ case reports2025
Successful long-term treatment of tubulointerstitial nephritis and uveitis with mycophenolate.
Article in BMJ case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tubulointerstitial nephritis and uveitis (TINU) syndrome is characterised by bilateral anterior uveitis and acute kidney injury secondary to interstitial nephritis. Corticosteroids remain the cornerstone of therapy. There is little data around the use of steroid-sparing agents.We present a female in her sixth decade of life of Caucasian ethnicity who presented with acute kidney failure requiring dialysis from TINU. Systemic corticosteroids were commenced; however, she developed a cushingoid appearance, proximal myopathy and hyperglycaemia. Mycophenolate mofetil was initiated as a steroid-sparing agent with significant improvement in kidney function. She remains well 2.5 years later. Incidentally, she was noted to have a distant history of vulval sarcoidosis without any other evidence of active disease on imaging and a normal serum angiotensin-converting enzyme.This case demonstrates successful long-term outcomes of mycophenolate in the management of TINU.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.